JP Morgan increased its stake in Innovent Bio (01801) by approximately 2.55 million shares at a price of approximately HK$80.68 per share.
On October 30, Morgan Stanley increased its holdings in Sinopharm Group (01801) by 2,550,546 shares, with an average price of HK$80.6819 per share, for a total amount of approximately HK$206 million.
The latest data from the Hong Kong Stock Exchange shows that on October 30th, JP Morgan increased its holdings of INNOVENT BIO (01801) by 2,550,546 shares, with a price of 80.6819 Hong Kong dollars per share, for a total amount of approximately 206 million Hong Kong dollars. After the increase, JP Morgan now holds approximately 87.0232 million shares, accounting for 5.07% of the total shares.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
